Acme United Corporation filings document the formal disclosures of an operating company that supplies first aid and medical products, safety solutions and cutting technology. Its 8-K reports include operating and financial results, material-event disclosures, acquisition-related reporting, credit-facility matters and other corporate updates affecting the company's capital and operating structure.
ACU proxy and annual-meeting filings cover board elections, executive compensation votes, equity incentive plan amendments and auditor ratification. The company's regulatory record also includes material agreement disclosures, including amendments to its secured revolving credit facility, along with governance matters and shareholder voting results.
ACME United Corp director Susan H. Murphy sold 2,890 shares of common stock on November 3, 2026, for $67 per share. Her reported direct holdings after the sale were 5,967 shares. No Rule 10b5-1 plan is reported for the sale.
ACME UNITED CORP (ACU) director Brian Barker exercised employee stock options on November 3, 2026, to acquire 5,000 common shares at $21.75 per share. The exercise was effected on a net share settlement basis; 1,565 shares were delivered or withheld for payment of exercise price or tax liability. His reported Employee Stock Option position following the transaction was 12,500 shares. No Rule 10b5-1 plan is reported.
Acme United Corp. (ACU) director and President and COO Brian S. Olschan reported direct sales of 14,205 shares of common stock on November 2, 2026, at $69.14 per share, and 1,258 shares on November 4, 2026, at $71.52 per share. The Rule 10b5-1 plan checkbox was unchecked.
Acme United Corp. director Susan H Murphy reported a proposed sale of 2,890 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $200,305 and an approximate sale date of November 2, 2026. The shares are listed as acquired from the issuer through a stock option exercise on October 28, 2026, as compensation.
Acme United Corp. (ACU) President and COO Brian S. Olschan reported direct sales of 1,936 common shares on October 30, 2026, at $69.07 per share, and 508 common shares on October 29, 2026, at $69.16 per share. The reported sales total 2,444 shares. No Rule 10b5-1 plan is reported.
Acme United Corp. director Susan H. Murphy exercised options covering 5,000 common shares on October 29, 2026, at an exercise price of $28.20 per share. The exercise was effected on a net share settlement basis; 2,110 shares were delivered or withheld for payment of exercise price or tax liability, reported at $66.85 per share. Murphy directly held options covering 26,500 shares after the exercise, and no Rule 10b5-1 plan is reported.
ACME United Corp (ACU) reports Officer Brian Olschan’s proposed sale of 17,907 common shares through Fidelity Brokerage Services LLC, with an approximate sale date of October 29, 2026. The listed aggregate market value is $1,178,996.88. The notice lists the shares as acquired from the issuer as a stock award on October 28, 2026.
Acme United Corp (ACU) President and COO Brian S. Olschan reported exercising employee stock options on October 28, 2026: 35,000 shares at $23.05, 9,200 at $23.94 and 7,500 at $24.06. The corresponding common-stock entries report acquisitions in those amounts. Other common-stock entries report 27,702, 3,348 and 2,743 shares delivered or withheld for payment of exercise price or tax liability. A related footnote describes an option exercise as effected on a net share settlement basis.
Acme United Corporation reported third-quarter 2026 net sales of $58.0 million, up 18% from $49.1 million a year earlier; comparable sales excluding My Medic rose 10%. Net income increased 80% to $3.4 million, and diluted earnings per share rose 74% to $0.80. For the first nine months, sales were $173.0 million, up 16%, and net income was $9.5 million, up 14%.
Third-quarter gross margin was 45.3%, versus 39.1% a year earlier. The $6.0 million tariff refund included $4.0 million recognized as a reduction of cost of goods sold and $2.0 million recorded as an accrued liability as of September 30, 2026; the refund contributed approximately 690 basis points to gross margin, partly offset by approximately 310 basis points from $1.8 million of DMT facility closure costs.
Bank debt less cash was $29.7 million as of September 30, 2026, compared with $23.1 million a year earlier. Acme United generated approximately $13.8 million in free cash flow during the twelve months ended September 30, 2026, including $6.0 million in tariff refunds. The company plans to close its DMT plant in Massachusetts later this year; annual savings from the closure are expected to be more than $1.0 million in 2027.
Acme United Corporation (ACU) common stock: The Capital Management Corporation reported beneficial ownership of 375,161 shares, or 9.8% of the class, as of September 30, 2026. Pamela C. Simms, identified as the corporation’s Compliance Officer, signed the report.